Background: Infl ammatory diseases of the heart (myocarditis, pericarditis) are commonly caused by viruses. Among the human cardiotropic viruses, parvovirus B19, Coxsackie B viruses, and adenoviruses play a leading role. Aim: The aim of the present study was to determine the presumptive causative role of parvovirus B19, Coxsackie B viruses, and adenoviruses in the development of myocarditis, pericarditis and dilated cardiomyopathy by demonstrating the presence of specifi c antiviral antibodies or viral DNA in patients' serum samples.
Infl ammatory diseases of the heart clinically manifested as infl ammation of the myocardium (myocarditis) and the pericardium (pericarditis) are some of the challenging diagnoses in cardiology and are associated largely with different types of infectious agents. 1 A variety of cardiotropic viral, rickettsial, and bacterial infectious agents have been identifi ed to date. [2] [3] [4] The cardiotropic viruses adenovirus, enterovirus, Epstein-Barr virus, human herpes virus 6, parvovirus B19 (B19V) and cytomegalovirus, are common cough viruses. 2, 5 Although up to 90% of people will catch one or more of these viruses in their life without getting their heart affected, only a selected few develop clinical symptoms. 5 Myocarditis is marked by infl ammation and damage of the heart muscle. There are many causes of myocarditis, including viral infections, autoimmune diseases, environmental toxins, and adverse reactions to medications. The prognosis is variable but chronic heart failure is the major long term complication. Viruses are one of the most common infectious agents. They can enter cardiac myocytes and macrophages through specifi c receptors causing a cytotoxic effect. 2, 5 The infectious cause of myocarditis was originally determined in experimental and epidemiological studies in the 1950s and 1960s by investigating myocarditis patients' antibody responses to infectious agents indicating that patients had been exposed to them. These studies found that enteroviruses, including Coxsackie viruses, were present in myocarditis patients. With increasingly powerful ways to identify infectious diseases using molecular techniques in the 1980s, other viruses (including adenoviruses) were also found to be associated with myocarditis and the key role of parvovirus B19 was subsequently demonstrated. 2 The exact incidence of myocarditis remains unclear, partly due to the insensitivity of diagnostic tools used in previous studies. This may cause an underestimation of its true incidence. The prevalence of myocarditis has been found to be up to 42% in cases of unexplained deaths in people aged 35 or younger. [6] [7] [8] Therefore, a certain genetic background, either or not related to immune alterations, appears to be a requisite to develop clinical symptoms of myocarditis and/or progression to dilated cardiomyopathy following virus infection in the heart.
The diagnostic gold standard is endomyocardial biopsy with the histological Dallas criteria in conjunction with the new tools of immunohistochemistry and viral PCR 5 , according to the 1995 WHO classifi cation of cardiomyopathies 9 . Traditional serological studies, peripheral viral cultures, have been used to identify the most frequent pathogens for viral myocarditis in the past. Unfortunately, these methods lack sensitivity and specifi city. 10 When seroconversion (low IgG, raised IgM, and IgA) occurs at the time of the cardiac symptoms, it may suggest viral cardiac manifestation.
The purpose of this study was to determine the presumptive causative role of three cardiotropic viruses (parvovirus B19, Coxsackie B viruses, and adenoviruses) in the development of myocarditis, pericarditis, and dilated cardiomyopathy by demonstrating the presence of specifi c antiviral antibodies or viral DNA in patients' serum samples.
In the present study we analyze the prevalence of the three major human cardiotropic viruses in patients who have not undergone biopsy but have presented with an infl ammatory heart disease or cardiac complaints. The assays we use do not prove directly virus infection in the heart due to the high background prevalence, but can be helpful in making a presumptive diagnosis in a selected patient group who do not undergo endomyocardial biopsy for additional PCR and immunohistochemical analysis of infl ammation. 5 
MATERIALS AND METHODS

CLINICAL SAMPLES
We tested serum samples collected between 2010 and 2014 from 235 patients with myocarditis (108), pericarditis (79), myopericarditis (19) , dilated cardiomyopathy (DCM) (7), and fever of unknown origin accompanied by cardiac complaints (22). The mean age of patients with the standard deviation was 33±18 years.
LABORATORY ANALYSES -Serological methods -detection of specifi c IgM/ IgG antibodies to parvovirus B19 by commercial indirect enzyme-linked immunosorbent assay (Euroimmun, Anti-Parvovirus B19 ELISA (IgM/ IgG)) and IgM antibodies to Coxsackie B viruses (SERION ELISA classic Coxsackievirus IgM tests) and adenoviruses (Euroimmun Anti-Adenovirus ELISA (IgM) kit). The assays were performed as recommended by the manufacturer and the results were interpreted qualitatively as positive, negative or equivocal. -Molecular methods -parvovirus B19 DNA extraction from all serum samples was performed using the PureLink® Viral RNA/DNA test kits. Screening for B19V DNA was performed with primers e1905f and e1987r (20 p/mol) located in the NS1 gene (NS1-PCR) 11 Table 1) .
The serum samples of the 63 Coxsackie B virus IgM negative patients were tested for presence of adenovirus IgM antibodies (Table 2) . Positive results were obtained in 6 (9%, 95% CI 1.95-16.05), 4 patients with pericarditis (9%, 95% CI 0-18%) and in 2 patients (40%, 95% CI 12-68%) with fever of unknown origin, respectively.
Every IgM negative sample (n = 189) for Coxsackie B and adenovirus was tested by ELISA for specifi c parvovirus B19 IgM/IgG antibodies. B19-IgM antibodies were detected in 14 (7.4%, 95% CI 3-11%) of the samples (Table 3 ). The percentages of B19-IgM antibodies were 8% (7/90), 5% (3/63), NA -not available and 31% (4/13) in the patients with myocarditis, pericarditis and fever of unknown origin, respectively. Protective B19-IgG antibodies that reveal a past parvovirus B19 infection were found in 108 (57%, 95% CI 50-64%) of the samples. All positive B19-IgM and B19-IgG serum samples were tested for the presence of B19-viral DNA. A PCR signal was detected in all the patients who were B19-IgM positive, and in only 1 patient with a positive B19-IgG result, the latter presenting with dilated cardiomyopathy (Table 3) .
The patients studied in this report were divided into seven age groups and the highest number were in the age groups 20-29 years (n=46) and 30-39 (n=45) or 39% (91/235) of all tested, respectively (Fig. 1) .
The highest number of ELISA IgM positive samples for the three causative viral agents tested were in the age groups 20-29 (25/46, 54%, Fig.  1 ) and 0-9 (10/30, 33%, Fig. 1 ). They were 25/60 (42%) and 10/60 (17%) from all IgM positive, respectively (Fig. 2) . The lowest number were in the groups of patients above 40 (7/60, 12%, Fig. 2 ).
DISCUSSION
Infl ammatory diseases of the heart (myocarditis, pericarditis) are commonly caused by viruses and more than 20 of them can induce myocarditis in humans.
The assays applied in the present study do not use biopsy materials for direct viral detection and do not reveal directly virus infection of the heart. They also do not cover all potential infectious causative agents of infl ammatory heart disease (Epstein-Barr virus, herpes simplex virus, cytomegalovirus, Rickettsia conorii, Chlamydia, etc.). Despite these limitations of the study, the tested panel of carefully selected and analyzed samples (more than 200) over a period of fi ve years (results described here) provides enough evidence for the leading role of parvovirus B19, Coxsackie B virus, and adenovirus infections in the pathogenesis of myocarditis and pericarditis.
In the present study, 60 (25.5%) patients' samples of all tested (n=235) were positive for acute viral infection (Coxsackie B viruses, parvovirus B19 or adenoviruses). Positive serological IgM results for Coxsackie B viruses were found in 40/235 (17%). These viruses are estimated to be responsible for at least 50% of the cases of infection-caused heart diseases. 12 We found adenovirus IgM antibodies in 6 patients, the results similar to those reported by Towbin 13 concerning adenovirus participation in the development of myocarditis and pericarditis in adolescents and adults. These data are consistent with the overall frequency of viral pathogens causing infl ammatory diseases of the heart 14-16 which for Coxsackie B viruses and adenovirus are 20 -40% and 1.6%, respectively. Many authors have reported high prevalence of B19V as a leading cardiotropic virus. 2, 17, 18 In this regards Bowles еt al. 2 reported an interesting trend of the increasing number of reports on parvovirus B19 associated myocarditis and DCM and we proved acute B19V infection in 14 (7%) of the tested patients mainly with diagnosis myocarditis.
Cardiac disease becomes apparent about two weeks after exposure to the virus. 12, 19 In adults, viral myocarditis and dilated cardiomyopathy can occur if the virus infects the heart muscle. For reasons yet unknown, the cardiac disease caused by these viruses mainly occurs in middle-aged men, with onset occurring, on average, around age 42 19 , and our data about the age of the affected were similar.
About the clinical diagnoses, the most affected with positive results for specific IgM antiviral antibodies were patients with myocarditis (25/60, 41.66%) and pericarditis (19/60, 31.66%).
CONCLUSION
The present study confi rms the involvement of Coxsackie B viruses, parvovirus B19, and adenoviruses in the development of infl ammatory diseases of the heart (myocarditis and pericarditis). As expected Coxsackie B viruses were with the highest frequency of proof among the tested cardiotropic viruses, namely they were found in 40 samples (17%). This is the fi rst study in Bulgaria to simultaneously analyze the three major human cardiotropic viruses as causative agents of infl ammatory heart disease. It reveals the important role of a comprehensive etiological diagnosis of infl ammatory diseases of the heart.
